Cue Biopharma, Inc. Certificates of Deposit, at Carrying Value
Cue Biopharma, Inc. (CUE) had Certificates of Deposit, at Carrying Value of $50.00 thousand as of 2018-03-31, per its 10-Q filed 2018-05-14.
Discontinued › Notes
us-gaap:CertificatesOfDepositAtCarryingValue · last filed 2018-05-14
- 2018-03-31: Certificates of Deposit, at Carrying Value $50.00K.
- 2017-12-31: Certificates of Deposit, at Carrying Value $50.00K.
| Period end | Certificates of Deposit, at Carrying Value |
|---|---|
| 2018-03-31 | $50.00K 10-Q · filed 2018-05-14 |
| 2017-12-31 | $50.00K 10-Q · filed 2018-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Akebia Therapeutics, Inc. (AKBA) | United States | $0.255B | -10.35 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |